250 related articles for article (PubMed ID: 19205427)
1. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
2. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].
Shchegolev AIu; Sidorova TA; Severina IS
Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005
[TBL] [Abstract][Full Text] [Related]
3. [Potentiation of NO-dependent activation of soluble guanylyl cyclase by 5-nitroisatin and antiviral preparatation arbidol].
Severina IS; Shchegolev AIu; Medvedev AE
Biomed Khim; 2013; 59(3):295-304. PubMed ID: 23987067
[TBL] [Abstract][Full Text] [Related]
4. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
Severina IS; Piatakova NV; Shchegolev AIu
Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
[TBL] [Abstract][Full Text] [Related]
5. [Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives].
Severina IS; Pyatakova NV; Shchegolev AY; Rozhkov VY; Batog LV; Makhova NN
Biomed Khim; 2015; 61(6):705-11. PubMed ID: 26716741
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole.
Chien WL; Liang KC; Teng CM; Kuo SC; Lee FY; Fu WM
Mol Pharmacol; 2003 Jun; 63(6):1322-8. PubMed ID: 12761342
[TBL] [Abstract][Full Text] [Related]
7. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
Schmidt K; Schrammel A; Koesling D; Mayer B
Mol Pharmacol; 2001 Feb; 59(2):220-4. PubMed ID: 11160856
[TBL] [Abstract][Full Text] [Related]
9. YC-1-like potentiation of NO-dependent activation of soluble guanylate cyclase by derivatives of protoporphyrin IX.
Severina IS; Pyatakova NV; Shchegolev AY; Ponomarev GV
Biochemistry (Mosc); 2006 Mar; 71(3):340-4. PubMed ID: 16545073
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
Bellamy TC; Garthwaite J
Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
[TBL] [Abstract][Full Text] [Related]
11. A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding.
Koglin M; Behrends S
J Biol Chem; 2003 Apr; 278(14):12590-7. PubMed ID: 12560334
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
13. Regulation of nitric oxide-sensitive guanylyl cyclase.
Friebe A; Koesling D
Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
[TBL] [Abstract][Full Text] [Related]
15. BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase.
Koglin M; Stasch JP; Behrends S
Biochem Biophys Res Commun; 2002 Apr; 292(4):1057-62. PubMed ID: 11944922
[TBL] [Abstract][Full Text] [Related]
16. YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages.
Hwang TL; Tang MC; Kuo LM; Chang WD; Chung PJ; Chang YW; Fang YC
Toxicol Appl Pharmacol; 2012 Apr; 260(2):193-200. PubMed ID: 22381622
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
Miraglia E; De Angelis F; Gazzano E; Hassanpour H; Bertagna A; Aldieri E; Revelli A; Ghigo D
Reproduction; 2011 Jan; 141(1):47-54. PubMed ID: 20965947
[TBL] [Abstract][Full Text] [Related]
18. Antitumor antibiotic streptonigrin and its derivatives as inhibitors of nitric oxide-dependent activation of soluble guanylyl cyclase.
Severina IS; Pyatakova NV; Postnikov AB; Preobrazhenskaya MN; Khropov YV
Eur J Pharmacol; 2004 Jan; 483(2-3):127-32. PubMed ID: 14729099
[TBL] [Abstract][Full Text] [Related]
19. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
[TBL] [Abstract][Full Text] [Related]
20. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]